Why Molecular Templates (MTEM) Stock Is Down 60%

Written by Emily J. Thompson, Senior Investment Analyst

MTEM%

Source: Benzinga

Updated: Dec 20 2024

0mins

Source: Benzinga

Molecular Templates Inc Delisting Notice: The company received a delisting notice from Nasdaq due to its classification as a "public shell" and failure to meet listing requirements, including not filing its quarterly report and maintaining a minimum stock price.
Stock Trading Impact: Following the announcement, shares of Molecular Templates fell by 60% to 13 cents, with trading set to be suspended on December 26, and the company does not plan to appeal the decision.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Why Molecular Templates (MTEM) Stock Is Down 60%

About the author

Top News

Oil Firms Cautious on Venezuela Investment Push

GM Reports $7.1 Billion Charge Amid EV Shift

Stock Market Wraps 2025 with Double-Digit Gains

Novo Nordisk's Weight-Loss Pill Approval: Key Impacts

Related Articles

Bragar Eagel & Squire Files Class Action Against Alexandria for 2025 Losses

Texas Becomes First State to Purchase $5 Million Bitcoin via ETF

Sigh Up to Get Intellectia Insights

How did the company's recent strategic decisions impact its latest financial performance?

Can you explain the factors behind the recent changes in the company's stock price?

What are the expected impacts of current market trends on the company's future growth?

Based on the latest earnings report, what are the company's forecasted revenues for the next quarter?

How does the company's performance compare to its main competitors in the same sector?

People Also Watch